Description
Immune cells and their secreted factors have a large influence on cardiovascular pathologies. This conference will highlight the molecular role of myeloid cells and lymphocytes in atherogenesis and talks will be given by leading specialists in the field. Atheromas are dynamic lesions of dysfunctional endothelial and smooth muscle cells driven by infiltrating inflammatory monocyte/macrophages, mast cells or lymphocytes. The recent observations of possible anti-inflammatory roles of immune cell subpopulations and potential therapeutical interventions will be discussed.
